PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Gibson, C. Michael
TI  - Phase 2 Trial Provides Safety and Outcomes Data on Novel Anticoagulant Agent
DP  - 2009 Feb 01
TA  - MD Conference Express
PG  - 14--15
VI  - 8
IP  - 8
4099  - http://mdc.sagepub.com/content/8/8/14.2.short
4100  - http://mdc.sagepub.com/content/8/8/14.2.full
AB  - Despite the advent of dual antiplatelet therapy with aspirin and clopidogrel, rates of in-hospital and 1-year mortality and reinfarction after acute coronary syndrome (ACS) are approximately 10%. The results of the ATLAS ACS-TIMI 46 [NCT00402597] trial represent an important step toward meeting a need for more effective antithrombotic therapy after ACS.